RCKT · ROCKET PHARMACEUTICALS, INC.

NasdaqHealthcareBiotechnology

Rocket Pharmaceuticals Inc Is A Late-Stage Biopharmaceutical Company. It Is Focused On The Development Of Gene Therapies For Rare And Devastating Pediatric Diseases. The Pipeline Products Of The Company Include Rp-A501 For Danaon Disease, Rp-L102 For Fanconi Anemia, Rp-L201 For Leukocyte Adhesion, Rp-L301 For Pyruvate Kinase Deficiency, And Rp-L401 For Infantile Malignant Osteopetrosis. It Has One Reportable Segment Related To R&D And Commercial Readiness Of Its Gene Therapies.

HealthcareNasdaqUS

FLOAT

84.6M

FREE FLOAT %

77%

SHARES O/S

109.8M

MARKET CAP

$251.4M

EXCHANGE

Nasdaq

COUNTRY

RCKT Catalyst History

No catalysts recorded for RCKT yet

Day Trader Sniper hasn't classified a publishable catalyst for RCKT yet. New events appear here as they're scored.

Be early on the next RCKT spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

RCKT · ROCKET PHARMACEUTICALS, INC.

RCKT Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.